61019-27-0Relevant articles and documents
Investigation of the electronic properties of solvents (water, benzene, methanol) using IEFPCM model, spectroscopic investigation with docking and MD simulations of a thiadiazole derivative with anti-tumor activities
Al-Wahaibi, Lamya H.,Mary, Y. Sheena,Shyma Mary,Al-Mutairi, Aamal A.,Hassan, Hanan M.,El-Emam, Ali A.,Yadav, Rohitash
, (2021/11/30)
6-(4-Chlorophenyl)-3-(thiophen-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]-thiadiazole (CLP) was synthesized and spectroscopic investigations have been made experimentally and theoretically. The electrostatic potential maps showed the reactive sites in CLP compound and its halogenated derivatives. The various chemical descriptors and NLO properties are predicted and compared for CLP with its halogenated derivatives. The stability of CLP was studied with NBO analysis. For diverse solvents (water, benzene, and methanol) and gas phase, UV–vis spectra are being used to assess the electronic transition. Binding affinities with target protein were carried out which gave the effects of bio-efficiency due to the halogen substitution. The binding affinity values were increasing from that of the parent molecule and are high for meta substitutions (with chlorine positional changes). The MD simulations and docking studies suggested inhibitory activity against CDK2 and could be considered as anticancer candidates.
Synthesis and biological evaluation of novel glycosyl-containing 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole derivatives as acetylcholinesterase inhibitors
Liu, Xiu-Jian,Wang, Lei,Yin, Long,Cheng, Feng-Chang,Sun, Hui-Min,Liu, Wei-Wei,Shia, Da-Hua,Caoa, Zhi-Ling
, p. 571 - 575 (2017/11/14)
An efficient protocol for the synthesis of novel glycosyl-containing 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole derivatives starting from the commercially available d-glucosamine hydrochloride is described by reaction of glycosyl isothiocyanate with various aminotriazoles in DMF. Glycosyl isothiocyanate is an important intermediate and synthetic methods are discussed. The acetylcholinesterase inhibitory activity of these compounds was tested by Ellman’s method. It was found that most compounds exhibited over 90% inhibition and they were subsequently evaluated for their IC50values.
INHIBITORS OF UDP-GALACTOPYRANOSE MUTASE
-
Paragraph 0360-0361; 0362, (2017/09/25)
Compounds and salts thereof which are acyl-sulfonamides or certain carboxylic acids and which inhibit microbial growth or attenuate the virulence of pathogenic microorganisms and which inhibit UDP-galactopyranose mutase (UGM). Compounds of the invention include 2-aminothiazoles and triazolothiadiazines, particularly 3,6,7-substituted-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines, and 2-amino and salts thereof. Methods for inhibiting growth or attenuating virulence of microbial pathogens including mycobacterium, for example, M. tuberculosis and M. smegmatis and Klebsiella, for example, Klebsiella pneumoniae. Methods for inhibiting eukaryotic human and animal pathogens, and fungi and nematodes in particular. Methods for treatment of infections by prokaryotic and eukaryotic pathogens employing compounds of the invention.